Total Funding
59
58
Total FundingGrant raised
Growth Score
-5 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
55632
Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.
- Joseph Payne: President and CEO
- Pad (Padmanabh) Chivukula: Founder, CSO & COO
About the Company
Arcturus Therapeutics is a late-stage clinical mRNA medicine company that focuses on developing novel RNA therapeutics for the treatment of various rare diseases. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and a patent portfolio (32 patents, USPTO granted) that allow the targeting of any gene in the human genome.
It was
founded in 2013 and is headquartered in San Diego, California.
